358026BR
5月 08, 2023
Switzerland
About the Role
Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With a strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly.
Early HEOR Directors will work in partnership with Global TAs, other MAP functions, Regions, and priority countries, as well as R&D (NIBR & GDD) to develop and implement impactful HEOR and access-relevant evidence generation strategies and tactics that enable better patient outcomes, increased access, enhanced value proposition, and that support new commercial models. They will ensure HTA and payer evidence requirements are built into TPPs, clinical development plans, integrated evidence plans, and integrated product strategies.
Early HEOR Directors will be responsible to develop and deliver all aspects of the HEOR strategy and execution for priority assets from (pre-) POC up to FDP. This role will specifically focus on early assets residing within Global TA teams, up until assets transition to International TA teams. With Global TAs, early HEOR Directors will co-develop HEOR strategies and tactics with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g. Italy and/or Spain) needs and feasibility. They will work in close partnership, collaborate and influence strategic TAs cross-functional teams, GPTs, R&D teams in NIBR & GDD, Region and priority Country teams to maximize patient outcomes and access and healthcare system value for early IM assets
Your responsibilities include, but are not limited to:
Your responsibilities:
Your responsibilities include, but are not limited to:
• Responsible for delivering winning HEOR strategy and tactics, with high quality and on-time availability, including outcomes research and other relevant access and healthcare systems evidence and HEOR deliverables (incl. Global Value Dossier, Cost-effectiveness Models, Budget Impact Models, evidence synthesis, PCO or PRO strategy, access-enabling studies, etc.)
• Ensure that payer and healthcare needs are reflected into pivotal clinical programs as well as phase 3b/4, RWE and integrated evidence plans to meet the needs of external experts and institutions involved in reimbursement, pricing, access and healthcare systems decisions.
• Oversee delivery of access-relevant evidence required by country teams in prioritized markets to achieve reimbursement and other positive funding recommendations and optimal access.
• Establish and maintains relationships with key economic modelling, outcomes research and HEOR talent and leaders in the field, both outside and inside the company; facilitate sharing of learnings and hands-on utilization of HEOR deliverables and evidence throughout the organization.
• Stay abreast of internal and external developments, trends and other dynamics that affect the HEOR and HTA domain and shares learnings with team and the broader organization.
• Support Head of Early HEOR, as well as Head of HEOR & PCO in external engagement (with HTA bodies, policy makers, regulatory agencies, HEOR scientific groups) to shape the HTA environment, the HEOR field and informs the organization on opportunities and risks.
• Build strong partnerships within Value & Access, Medical Affairs, Global TAs, regional and country counterparts. Collaborate with global regulatory, therapy area policy and access colleagues in seeking early scientific advice from payer, policy maker, and regulatory agencies in prioritized countries.
• Embrace change, help implement the new ways of working from Transforming for Growth, develop and improve improved ways of working with a focus on flexibility and efficiency.
Early HEOR Directors will work in partnership with Global TAs, other MAP functions, Regions, and priority countries, as well as R&D (NIBR & GDD) to develop and implement impactful HEOR and access-relevant evidence generation strategies and tactics that enable better patient outcomes, increased access, enhanced value proposition, and that support new commercial models. They will ensure HTA and payer evidence requirements are built into TPPs, clinical development plans, integrated evidence plans, and integrated product strategies.
Early HEOR Directors will be responsible to develop and deliver all aspects of the HEOR strategy and execution for priority assets from (pre-) POC up to FDP. This role will specifically focus on early assets residing within Global TA teams, up until assets transition to International TA teams. With Global TAs, early HEOR Directors will co-develop HEOR strategies and tactics with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g. Italy and/or Spain) needs and feasibility. They will work in close partnership, collaborate and influence strategic TAs cross-functional teams, GPTs, R&D teams in NIBR & GDD, Region and priority Country teams to maximize patient outcomes and access and healthcare system value for early IM assets
Your responsibilities include, but are not limited to:
Your responsibilities:
Your responsibilities include, but are not limited to:
• Responsible for delivering winning HEOR strategy and tactics, with high quality and on-time availability, including outcomes research and other relevant access and healthcare systems evidence and HEOR deliverables (incl. Global Value Dossier, Cost-effectiveness Models, Budget Impact Models, evidence synthesis, PCO or PRO strategy, access-enabling studies, etc.)
• Ensure that payer and healthcare needs are reflected into pivotal clinical programs as well as phase 3b/4, RWE and integrated evidence plans to meet the needs of external experts and institutions involved in reimbursement, pricing, access and healthcare systems decisions.
• Oversee delivery of access-relevant evidence required by country teams in prioritized markets to achieve reimbursement and other positive funding recommendations and optimal access.
• Establish and maintains relationships with key economic modelling, outcomes research and HEOR talent and leaders in the field, both outside and inside the company; facilitate sharing of learnings and hands-on utilization of HEOR deliverables and evidence throughout the organization.
• Stay abreast of internal and external developments, trends and other dynamics that affect the HEOR and HTA domain and shares learnings with team and the broader organization.
• Support Head of Early HEOR, as well as Head of HEOR & PCO in external engagement (with HTA bodies, policy makers, regulatory agencies, HEOR scientific groups) to shape the HTA environment, the HEOR field and informs the organization on opportunities and risks.
• Build strong partnerships within Value & Access, Medical Affairs, Global TAs, regional and country counterparts. Collaborate with global regulatory, therapy area policy and access colleagues in seeking early scientific advice from payer, policy maker, and regulatory agencies in prioritized countries.
• Embrace change, help implement the new ways of working from Transforming for Growth, develop and improve improved ways of working with a focus on flexibility and efficiency.
Diversity & Inclusion / EEO
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Role Requirements
What you’ll bring to the role:
• Significant experience in HEOR or RWE roles to senior level in the pharmaceutical industry.
• Advanced Degree; preferably Ph.D., M.D., MBA, RPh or equivalent
• Substantial subject matter expertise in HEOR, incl. deep understanding of HEOR and other approaches to generate payer and HCS evidence; preferably subject matter expertise in RWE, capability in designing winning access-relevant RWE studies, analyzing and publishing RWE data and using the results to make impact with access-relevant customers
• Customer-centric mindset, passion, strong knowledge and alignment to payer, patient, access, HCS customers mindset, evidence requirements and decision-making dynamics; deep understanding of payer/HTA evidence requirements and decision-making dynamic cross countries/regions (preferably: an active external network with HEOR, RWE and health policy OLs)
• Significant experience working in global or above-country multidisciplinary drug development and product teams, incl. proven track record of influencing development plans or IEPs to meet the needs of payers or other HCS decision makers; influencing in matrix organization balancing cross-functional perspectives and alignment with business priorities
• Strong knowledge of research methodology and statistical methods in the field of data analysis, and considerable experience collaborating with quantitative scientists and analysts
• Impact-oriented, enterprise and agile mindset with proven track record of fostering innovation, ability to lead in agile organisation, and strong process/project management skills
• Preferred: Significant and recent (post 2015) US in-market experience: includes working in the US market with the local US customers, US health care systems / systems of care, US payors / accounts, US market strategy etc
.
You’ll receive:
Competitive salary, Annual bonus, Pension scheme, Share scheme, Health insurance, 25 days annual leave, Flexible working arrangements, subsidized dining facilities, Employee recognition scheme, learning and development opportunities.
Why consider Novartis?
766 million. That’s how many lives our products touched in 2021. And while we’re proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given opportunities to explore the power of digital and data. Where you’re empowered to risk failure by taking smart risks, and where you’re surrounded by people who share your determination to tackle the world’s toughest medical challenges.
Imagine what you could do at Novartis!
Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to learn more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
We are Novartis. Join us and help reimagine medicine.
#LI-NOV = Novartis
• Significant experience in HEOR or RWE roles to senior level in the pharmaceutical industry.
• Advanced Degree; preferably Ph.D., M.D., MBA, RPh or equivalent
• Substantial subject matter expertise in HEOR, incl. deep understanding of HEOR and other approaches to generate payer and HCS evidence; preferably subject matter expertise in RWE, capability in designing winning access-relevant RWE studies, analyzing and publishing RWE data and using the results to make impact with access-relevant customers
• Customer-centric mindset, passion, strong knowledge and alignment to payer, patient, access, HCS customers mindset, evidence requirements and decision-making dynamics; deep understanding of payer/HTA evidence requirements and decision-making dynamic cross countries/regions (preferably: an active external network with HEOR, RWE and health policy OLs)
• Significant experience working in global or above-country multidisciplinary drug development and product teams, incl. proven track record of influencing development plans or IEPs to meet the needs of payers or other HCS decision makers; influencing in matrix organization balancing cross-functional perspectives and alignment with business priorities
• Strong knowledge of research methodology and statistical methods in the field of data analysis, and considerable experience collaborating with quantitative scientists and analysts
• Impact-oriented, enterprise and agile mindset with proven track record of fostering innovation, ability to lead in agile organisation, and strong process/project management skills
• Preferred: Significant and recent (post 2015) US in-market experience: includes working in the US market with the local US customers, US health care systems / systems of care, US payors / accounts, US market strategy etc
.
You’ll receive:
Competitive salary, Annual bonus, Pension scheme, Share scheme, Health insurance, 25 days annual leave, Flexible working arrangements, subsidized dining facilities, Employee recognition scheme, learning and development opportunities.
Why consider Novartis?
766 million. That’s how many lives our products touched in 2021. And while we’re proud of that fact, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given opportunities to explore the power of digital and data. Where you’re empowered to risk failure by taking smart risks, and where you’re surrounded by people who share your determination to tackle the world’s toughest medical challenges.
Imagine what you could do at Novartis!
Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to learn more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
We are Novartis. Join us and help reimagine medicine.
#LI-NOV = Novartis
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: https://talentnetwork.novartis.com/network
PHARMA
GLOBAL PRODUCT & PORTFOLIO STRATEGY
Switzerland
Basel
Novartis Pharma AG
Ireland
United Kingdom
Market Access
Full Time
Regular
No
